Crestor, also known as Rosuvastatin, is a prescription medication used to lower cholesterol and reduce the risk of cardiovascular diseases in adults. It is available as an oral tablet and oral suspension (OASD).
Rosuvastatin is used to treat high cholesterol and reduce the risk of cardiovascular diseases in adults. It may also be prescribed for other medical conditions as determined by your doctor.
Take this medication as your doctor has instructed you to, and if you are taking it regularly, it works best if you take it at the same time every day.
You must follow your doctor’s instructions when taking this medication. He or she will cause a small amount of medication to leave the body with the most cholesterol, triglycerides, or with other cholesterol, and that can affect how much medication is removed from the body.
Crestor must be taken exactly as prescribed. Do not take more or less of it or take it more often than your doctor tells you.
Some side effects of Crestor are mild or severe. These side effects are usually temporary and do not require medical attention and will resolve on its own or with the spread of the infection.
Less serious side effects are rare.
are mild and may not affect every person. The most common side effects are listed at the end of this leaflet.
are temporary and will usually subside on its own or with the spread of infection.
are mild and may not subside on its own or with the spread of infection.
Store Crestor at room temperature, away from moisture and heat.
Only use Crestor as prescribed by your doctor. Do not drink alcohol or take it with other medications that you are using to prevent potential side effects from it from getting worse. If you suspect overdose, contact your local poison control center or emergency room immediately.
Check the expiration date on the Crestor carton. The information displayed below from the manufacturer is for reference only. The date of the last available date on the carton was selected based on the year at which the medication was released from the brand product.
In order to help you find out more about the expiration date, refer to the following list of tips.
| Active Ingredient (or Chemical) | Chemical | Effects |
|---|---|---|
| Rosuvastatin | Rosuvastatin HCl | Treating high cholesterol and reducing risk factors. |
| Crestor | Rosuvastatin, Extended Release | Treating symptoms of high cholesterol and reducing risk factors. |
The active ingredient in Crestor is Rosuvastatin. The rest of the ingredients are listed at the end of this leaflet.
If you’re looking for a reliable solution to help manage your cholesterol levels, Crestor may be the solution you’ve been looking for. By targeting two key enzymes in cholesterol production, Crestor can help reduce high cholesterol levels, lower your risk of heart attacks and strokes, and even help prevent cardiovascular disease. By targeting two separate pathways in the body, Crestor can help reduce inflammation, increase HDL levels, and improve HDL levels in the blood. This targeted approach helps you feel more confident about your health, making it easier to manage your cholesterol levels effectively. It’s important to understand Crestor’s potential side effects and the importance of adhering to prescribed dosages and frequency to minimize these risks. Consult with your healthcare provider to understand the best course of action for you and ensure Crestor’s effectiveness and safety.
Cholesterol, or “bad” blood, plays a crucial role in many functions, including cardiovascular health. It’s a key component of the body’s natural response to stress, and Crestor is a valuable tool in this respect. By targeting specific enzymes in cholesterol production, Crestor can help reduce inflammation, increase HDL levels, and improve your HDL level. This targeted approach helps you feel more confident about your health and make healthier lifestyle choices.
Cholesterol-lowering medications are a cornerstone of managing cholesterol levels. One such medication is Rosuvastatin, widely recognized for its role in reducing inflammation and lowering LDL (bad) cholesterol levels. By targeting these enzymes in cholesterol production, Crestor may help lower LDL cholesterol levels and improve HDL levels, which are crucial for overall health. This targeted approach helps you feel more confident in your health and make healthier lifestyle choices.
If Crestor isn’t effective, you may need to consider a combination of lifestyle changes and medication. Some medications and lifestyle changes can help lower your cholesterol levels without causing severe side effects. Here’s how:
By combining Crestor with lifestyle changes and medication, you can help lower cholesterol levels without causing severe side effects. Whether you’re looking to lower your cholesterol or manage high cholesterol with Crestor, Crestor is your ally in maintaining your overall health and well-being.
Cholesterol-lowering medications, like Crestor and simvastatin, are highly effective in lowering LDL cholesterol. One such medication is Crestor, a statin medication that blocks the effects of LDL cholesterol production. By targeting these enzymes in cholesterol production, Crestor may help lower LDL cholesterol levels, improve HDL levels, and lower the risk of cardiovascular disease.
While Crestor offers hope for managing cholesterol levels effectively, it may not be the best choice for everyone. Common side effects may include nausea, diarrhea, stomach pain, and headache. It’s essential to communicate any side effects you experience with your healthcare provider to ensure Crestor is a safe and effective option for managing your cholesterol levels effectively.
Cholesterol-lowering medications, like Crestor and simvastatin, have been proven to be effective in lowering LDL cholesterol, especially in certain populations. By targeting these enzymes in cholesterol production, Crestor may help lower LDL cholesterol levels, improve HDL levels, and lower the risk of heart disease and stroke. This targeted approach helps you feel more confident and stay healthier while minimizing the risk of side effects.
AstraZeneca PLC is pleased with the significant increase in patients receiving Crestor® in the Philippines. This increase was maintained for three years after the company received a new drug application (NDA) for this indication. The increase in Crestor® patients is the largest increase of patients in over a six-year period in the PLC. The increase in Crestor® patients in the Philippines has been maintained for three years following the company receiving a new drug application (NDA) for this indication. AstraZeneca PLC is also pleased with the increased Crestor® patients in the Philippines and indicated that the patient population is now asymptomatic and at low risk for cardiovascular events, including the development of stroke and cardiovascular death. AstraZeneca PLC believes that the increased Crestor® patients in the Philippines are also at increased risk of developing a number of conditions, such as cardiovascular disease, type 2 diabetes, coronary artery disease, and hypertension. The increased Crestor® patients in the Philippines are also at increased risk of the development of certain cancers and the risk of endometrial cancer. The increased Crestor® patients in the Philippines are also at increased risk of cardiovascular disease, and hypertension, which are the primary risk factors for cardiovascular events. The increased Crestor® patients in the Philippines have also been observed to be at increased risk of developing certain cancers and the risk of developing endometrial cancer. The increased Crestor® patients in the Philippines are also at increased risk of developing certain cancers. The increased Crestor® patients in the Philippines are also at increased risk of the development of certain cancers and the risk of the development of endometrial cancer. AstraZeneca PLC believes that the increased Crestor® patients in the Philippines are also at increased risk of the development of certain cancers, which are the primary risk factors for cardiovascular disease. The increased Crestor® patients in the Philippines are also at increased risk of developing certain cancers, which are the primary risk factors for cardiovascular disease. The increased Crestor® patients in the Philippines are also at increased risk of the development of certain cancers.
More InformationCrestor® is a brand name of rosuvastatin. Crestor® is the generic name for the brand name drug rosuvastatin. The increased Crestor® patients in the Philippines have been maintained for three years following the company receiving a new drug application (NDA) for this indication.
LONDON (AP) — AstraZeneca’s Crestor (rosuvastatin calcium) is about to lose its patent protection by mid-2017.
AstraZeneca has been seeking a cheaper alternative to rosuvastatin, the cholesterol drug from Pfizer that treats heart disease and high cholesterol.
The Anglo-Swedish drugmaker is preparing for significant price reductions in the coming months, as it loses patent protection on Crestor, which had a sales of $3.4 billion in 2015. AstraZeneca’s patent on the cholesterol drug is set to expire in late 2017, so it may not make any profits.
The Anglo-Swedish company recently announced plans to close its research division in the US. AstraZeneca said it would make a generic version of the blockbuster drug in the US in the second half of this year.
Ranbaxy has already made a deal to sell its rosuvastatin drug to Merck under the name Crestor.
AstraZeneca is also trying to retain the $10.3 billion it had already paid for Crestor in 2015, in exchange for keeping the company’s patent on the drug.
AstraZeneca has said it will keep a number of patents on Crestor until the patent deal is resolved, which it will announce in early 2018.
The Anglo-Swedish company also announced a $2.4 billion price reduction in July, after the United Kingdom-based company lost its patent protection on its cholesterol drug.
The Anglo-Swedish company will also sell its generic version of Crestor, or rosuvastatin, in the US from June 2014.
AstraZeneca is preparing for significant price reductions in the coming months, as it loses patent protection on its cholesterol drug Crestor.
The Anglo-Swedish company said it would make a generic version of the blockbuster drug in the US in the second half of this year.
“We are aware of the impact of this decision, and we will make a decision soon,” AstraZeneca’s chief executive, Steven Nissenson, said in a company news release.
AstraZeneca shares fell 11 cents to $36.45 in after-hours trading on the New York Stock Exchange.
AstraZeneca has already made a deal to sell its rosuvastatin drug to Merck under the name Crestor.
AstraZeneca is also trying to retain the $10.3 billion it had already paid for Crestor in 2015, in exchange for keeping its patent on the drug.
AstraZeneca will also sell its generic version of Crestor, or rosuvastatin, in the US from June 2014.
AstraZeneca has also made a deal to sell its generic version of Crestor, or rosuvastatin, in the US from June 2014.
AstraZeneca has said it will make a deal to sell its generic Crestor, or rosuvastatin, in the US from June 2014.
AstraZeneca will make a deal to sell its generic Crestor, or rosuvastatin, in the US from June 2014.
The Anglo-Swedish company has also been trying to retain the $10.3 billion it had already paid for Crestor, in exchange for keeping its patent on the drug.
“This deal is important because AstraZeneca is now planning to keep its $10.3 billion of the generic Crestor in its portfolio,” Nissenson, a spokesman for AstraZeneca, said in a statement.
AstraZeneca is also preparing for the first full-year price cuts in a potential range of between $4.60 and $5.20 per pill, or about one-third of the price of its cholesterol drug Lipitor.
The drugmaker said it would make a generic version of the blockbuster cholesterol drug in the US in the second half of this year.
Stade de France Pharmacy